dc.contributor.author |
Moyo‑Gwete, Thandeka
|
|
dc.contributor.author |
Madzivhandila, Mashudu
|
|
dc.contributor.author |
Makhado, Zanele
|
|
dc.contributor.author |
Ayres, Frances
|
|
dc.contributor.author |
Mhlanga, Donald
|
|
dc.contributor.author |
Oosthuysen, Brent
|
|
dc.contributor.author |
Lambson, Bronwen E.
|
|
dc.contributor.author |
Kgagudi, Prudence
|
|
dc.contributor.author |
Tegally, Houriiyah
|
|
dc.contributor.author |
Iranzadeh, Arash
|
|
dc.contributor.author |
Doolabh, Deelan
|
|
dc.contributor.author |
Tyers, Lynn
|
|
dc.contributor.author |
Chinhoyi, Lionel R.
|
|
dc.contributor.author |
Mennen, Mathilda
|
|
dc.contributor.author |
Skelem, Sango
|
|
dc.contributor.author |
Marais, Gert
|
|
dc.contributor.author |
Wibmer, Constantinos K.
|
|
dc.contributor.author |
Bhiman, Jinal N.
|
|
dc.contributor.author |
Ueckermann, Veronica
|
|
dc.contributor.author |
Rossouw, Theresa M.
|
|
dc.contributor.author |
Boswell, Michael T.
|
|
dc.contributor.author |
De Oliveira, Tulio
|
|
dc.date.accessioned |
2022-11-01T13:08:48Z |
|
dc.date.available |
2022-11-01T13:08:48Z |
|
dc.date.issued |
2021-06 |
|
dc.description.abstract |
No abstract available. |
en_US |
dc.description.department |
Internal Medicine |
en_US |
dc.description.librarian |
am2022 |
en_US |
dc.description.sponsorship |
The South African Medical Research Council, the Centers for Disease Control and Prevention, the ELMA South Africa Foundation, the Wellcome Trust, the Fogarty International Center of the National Institutes of Health, the FLAIR Fellowship program, the European and Developing Countries Clinical Trials Partnership 2 of the European Union Horizon 2020 program, the South African Research Chairs Initiative of the Department of Science and Innovation and the National Research Foundation. |
en_US |
dc.description.uri |
http://www.nejm.org |
en_US |
dc.identifier.citation |
Moyo‑Gwete, T., Madzivhandila, M., Makhado, Z. et al. 2021, 'Cross-reactive neutralizing antibody responses elicited by SARS-CoV-2 501Y.V2 (B.1.351)', New England Journal of Medicine, vol. 384, pp. 2161-2163, doi : 10.1056/NEJMc2104192. |
en_US |
dc.identifier.issn |
0028-4793 (print) |
|
dc.identifier.issn |
1533-4406 (online) |
|
dc.identifier.other |
10.1056/NEJMc2104192 |
|
dc.identifier.uri |
https://repository.up.ac.za/handle/2263/88065 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
Massachusetts Medical Society |
en_US |
dc.rights |
© 2021 Massachusetts Medical Society. |
en_US |
dc.subject |
Mutations |
en_US |
dc.subject |
Patients |
en_US |
dc.subject |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
en_US |
dc.subject |
South Africa (SA) |
en_US |
dc.title |
Cross-reactive neutralizing antibody responses elicited by SARS-CoV-2 501Y.V2 (B.1.351) |
en_US |
dc.type |
Article |
en_US |